In the United States, cardiovascular health is especially important. Heart disease is the leading cause of death in the U.S., and as many as 1.5 million people have been diagnosed with aortic stenosis ...

Researchers in China reported successful transcatheter aortic valve replacements using a novel repositionable and retrievable self-expanding valve in 10 patients with severe symptomatic aortic ...

People didn't have to wait long after transcatheter aortic valve replacement (TAVR or TAVI) to safely undergo noncardiac surgery, though suboptimal device performance should give pause for another ...

SAN ANTONIO -- The early experience of patients needing cardiac surgery after transcatheter aortic valve replacement (TAVR) has surgeons raising the alarm about the excess risks of these challenging ...

An Oct. 21 study in Circulation: Cardiovascular Quality and Outcomes found that most transcatheter aortic valve replacement programs are found in affluent metropolitan areas. Researchers identified ...

A transcatheter aortic valve replacement (TAVR) therapy was approved by the US Food and Drug Administration (FDA) for patients with severe aortic stenosis even without symptoms. This is the first FDA ...

CHICAGO — Five years after treatment, patients with severe aortic stenosis had comparable rates of all-cause mortality or disabling stroke, whether they received transcatheter aortic valve replacement ...

Carson Tahoe Health has completed its 50th Transcatheter Aortic Valve Replacement procedure. TAVR is a minimally invasive procedure that replaces a narrowed aortic valve without the need for ...